Dihydrocodeine BPM Phenyleph HCl and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Dihydrocodeine BPM Phenyleph HCl and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / dihydrocodeine / phenylephrine
Brand name:
Synonyms: n.a.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydrocodeine BPM Phenyleph HCl-Insulin degludec Subcutaneous
- Dihydrocodeine BPM Phenyleph HCl-Insulin detemir
- Dihydrocodeine BPM Phenyleph HCl-Insulin Detemir (Cartridges and Prefilled Syringes)
- Dihydrocodeine BPM Phenyleph HCl-Insulin Detemir (Vials)
- Dihydrocodeine BPM Phenyleph HCl-Insulin detemir Subcutaneous
- Dihydrocodeine BPM Phenyleph HCl-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Dihydrocodeine, Aspirin, and Caffeine
- Insulin degludec and liraglutide Subcutaneous-Dihydroergotamine
- Insulin degludec and liraglutide Subcutaneous-Dihydroergotamine injection
- Insulin degludec and liraglutide Subcutaneous-Dihydroergotamine Mesylate
- Insulin degludec and liraglutide Subcutaneous-Dihydroergotamine nasal
- Insulin degludec and liraglutide Subcutaneous-Dihydroergotamine Nasal Spray